| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 06/24/2008 | US7390629 Tumor-activated prodrug compounds and treatment |
| 06/24/2008 | US7390628 Microparticle-based diagnostic methods |
| 06/24/2008 | US7390510 Water soluble complex of hypericin and a polyvinylpyrrolidone; diagnosing and treating tumors |
| 06/19/2008 | WO2008073965A2 Multiple imaging mode tissue marker |
| 06/19/2008 | WO2008073856A2 Delivery of nanoparticles and/or agents to cells |
| 06/19/2008 | WO2008073851A2 Remotely triggered release from heatable surfaces |
| 06/19/2008 | WO2008073828A2 Compositions and methods for magnetic resonance imaging contrast agents |
| 06/19/2008 | WO2008073774A1 Systems and methods for detecting infrared emitting composites and medical applications therefor |
| 06/19/2008 | WO2008073352A1 Formation and rejuvenation of organs and alcohol damaged organ regeneration through stem cell nutrients |
| 06/19/2008 | WO2008073292A2 Method for protecting renal tubular epithelial cells from radiocontrast nephro parhy (rcn) |
| 06/19/2008 | WO2008071742A1 Nanoparticle clusters and methods for forming same |
| 06/19/2008 | WO2008071679A1 Fibrin binding peptide conjugates for diagnostic and therapeutic applications. |
| 06/19/2008 | WO2008043101A3 Intraoperative imaging of hepatobiliary structures |
| 06/19/2008 | WO2008024951A3 Molecular imaging of epithelial cells in lymph |
| 06/19/2008 | WO2007149454A3 Imaging agents for use in magnetic resonance blood flow/perfusion imaging |
| 06/19/2008 | US20080147039 Vitreous body visualization agent |
| 06/19/2008 | US20080146784 Moncolonal antibody for use in diagnosis and treatment of cell proliferative disorders; immunotherapy; tissue engineering |
| 06/19/2008 | US20080145343 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
| 06/19/2008 | US20080145316 Skin coating with microbial indicator |
| 06/19/2008 | US20080145315 Bioassay for monitoring protein-protein interactions associated with absorption, distribution, metabolism and excretion in animals and/or cells |
| 06/19/2008 | US20080145314 EGFR inhibitors promote axon regeneration |
| 06/19/2008 | US20080145313 Treatment of cancer by means of RNA interference; compositions comprise small interfering nucleic acid molecule that suppresses expression of target gene involved in energy metabolism pathway within tumor cell, in biosynthesis of nucleotides, in glycogen metabolism, in transport of sugars, amino acids |
| 06/19/2008 | US20080145312 Diagnosing diseases involving altered neuropathology, including methods for rapid screening of mad cow disease and other transmissible spongiform encephalopathies; methods utilize visualization techniques such as optical coherence tomography |
| 06/19/2008 | US20080145311 Chelating agents with lipophilic carriers |
| 06/19/2008 | CA2671850A1 Delivery of nanoparticles and/or agents to cells |
| 06/19/2008 | CA2671843A1 Formation and rejuvenation of organs and alcohol damaged organ regeneration through stem cell nutrients |
| 06/19/2008 | CA2671806A1 Remotely triggered release from heatable surfaces |
| 06/18/2008 | EP1932544A1 Gene transfer for treating a connective tissue of a mammalian host |
| 06/18/2008 | EP1931735A1 High-purity texaphyrin metal complexes |
| 06/18/2008 | EP1931392A2 A fluorescent photoprobe for the imaging of endothelin receptors |
| 06/18/2008 | EP1931391A2 Optical imaging of rheumatoid arthritis |
| 06/18/2008 | CN101203248A 光学成像造影剂 Optical imaging contrast agents |
| 06/18/2008 | CN101200469A Separation of regioisomers of metal phthalocyanines |
| 06/18/2008 | CN101199863A Construction method of spleen deficiency of vital energy SHR animal model |
| 06/17/2008 | US7388124 Adjustment, compression of nervous systems; detection, monitoring variations in pain |
| 06/17/2008 | US7388024 Indeno[2,1A]indenes and isoindolo[2,1-A]indoles |
| 06/17/2008 | US7387773 Vaccine |
| 06/17/2008 | US7387771 dissolving in carrier liquid; drug linked to a protein-binding molecule via a spacer which is cleaved hydrolytically or enzymatically in the body of a subject in a pH-dependent manner; tissue targeted delivery; Doxorubicin-phenylacetylhydrazone spacer-maleimide |
| 06/12/2008 | WO2008070384A2 Method of preparing macromolecular contrast agents and uses thereof |
| 06/12/2008 | WO2008069974A1 Radiation enhancement agents for x-ray radiation therapy and boron neutron-capture therapy |
| 06/12/2008 | WO2008068939A1 Organic-inorganic hybrid particles containing contrast agent |
| 06/12/2008 | WO2008017944A3 Composition apparatus and method for use in imaging |
| 06/12/2008 | WO2007120579A3 Loaded latex optical molecular imaging probes |
| 06/12/2008 | WO2007106550A3 Methods and compositions for deterring abuse of orally administered pharmaceutical products |
| 06/12/2008 | US20080138396 rheumatoid arthritis, ulcerative colitis, Crohn's disease, inflammation, infections, osteomyelitis, atherosclerosis, organ transplant rejection, pulmonary fibrosis, sarcoidosis, and systemic sclerosis |
| 06/12/2008 | US20080138358 Protective protein comprising protease sequences from newly excysted juveniles for use in vaccination and prevention of parasitic infection of gut tissues |
| 06/12/2008 | US20080138292 Sensors for fluorescence and magnetic resonance imaging |
| 06/12/2008 | US20080138291 e.g. (4-Sulfamoylphenyl)thioureido fluorescein; bind to the enzyme under hypoxic conditions and are able to reverse the tumor acidification mediated by the enzyme; fluorescent dye for tumor detection by positron-emission tomography; antitumor, antiproliferative agent |
| 06/12/2008 | US20080138290 Core of perfluoropentane or dihydrodecafluoropentane encapsulated by a membrane-forming material such as phosphatidyl serines, cholines and/or glycerols; and a continuous phase aqueous medium; increases acoustic energy deposition at the target; uniformly dispersed; high speed intravenous installation |
| 06/12/2008 | US20080138289 Light emitting composite adapted for inserting into mammalian comprising a matrix material comprising a semiconductor nanocrystal or phosphor wherein the light emitting composite emits light of a wavelength range that is nonabsorbent to animal fluid or tissue; catheters, medical equipment; imaging |
| 06/12/2008 | US20080138288 Combinations for treatment of neovasculature |
| 06/12/2008 | US20080138287 3-substituted-2(arylalkyl)-1- azabicycloalkanes and methods of use thereof |
| 06/12/2008 | US20080138286 Using intradermal injection to deliver therapeutic proteins to patients |
| 06/12/2008 | US20080138285 for vascular lesion imaging and for diagnosing arteriosclerosis, ischemia with X-ray angiography and positron emission tomography; fluorinated steroid ester, glyceride compounds, phosphatidylcholine, and phosphatidylserine as membrane components of liposome |
| 06/12/2008 | US20080138284 Novel Peptides That Promote Lipid Efflux |
| 06/12/2008 | US20080138282 Radiolabeled Arylsulfonyl Compounds and Uses Thereof |
| 06/12/2008 | US20080138277 Drug delivery of therapeutic agent and carrier comprising targeting moiety that interacts with a target molecule such as chemokines, interferons, interleukins, osteoponting, chaperone proteins, receptors, and cellular adhesion molecules present in atherosclerotic lesions in blood vessels; diagnosis |
| 06/12/2008 | CA2707233A1 Organic-inorganic hybrid particles containing contrast agent |
| 06/11/2008 | EP1928513A2 Cell delivery fluid for prevention of cellsettling in delivery system |
| 06/11/2008 | EP1928507A2 Targeted contrast agents and methods for targeting contrast agents |
| 06/11/2008 | EP1239885B1 Interventions to mimic the effects of calorie restriction |
| 06/11/2008 | EP0979298B1 Metastasis models using green fluorescent protein (gfp) as a marker |
| 06/11/2008 | EP0954529B1 Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis |
| 06/11/2008 | CN101198351A Compositions and methods for treating conditions related to EPHRIN signaling with cupredoxins |
| 06/10/2008 | US7385395 Apparatus for preparing a solution of a hyperpolarized noble gas for NMR and MRI analysis |
| 06/10/2008 | US7385054 For use as contrast media; x-ray diagnosis and magnetic resonance imaging |
| 06/10/2008 | US7385041 Dual functioning excipient for metal chelate contrast agents |
| 06/10/2008 | US7384794 Using coated fiber to identify preferential particles in animal tissues; accurate assessment of concentrations of chemicals or drugs inside living animal |
| 06/10/2008 | US7384627 Antitumor agents with the use of HSV |
| 06/05/2008 | WO2008067079A2 Method and apparatus to identify vulnerable plaques with thermal wave imaging of heated nanoparticles |
| 06/05/2008 | WO2008067061A2 Compositions and methods for modulating angiogenesis |
| 06/05/2008 | WO2008067049A2 Particles for cell targeting |
| 06/05/2008 | WO2008065785A1 Novel compound having affinity for amyloid |
| 06/05/2008 | WO2008034621A3 Nucleotide phosphorylase for the prophylaxis, treatment or diagnosis of acute lung injury (ali) |
| 06/05/2008 | WO2007117657A3 Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency |
| 06/05/2008 | WO2007110804A3 Diagnostic systems and methods utilizing probe-ions exhibiting photon avalanche effect |
| 06/05/2008 | WO2007075565A3 Diagnostic system for the detection and diagnosis of skin cancer |
| 06/05/2008 | WO2007035405A3 In-vivo and in-vitro method for detecting amyloid deposits having at least one amyloidogenic protein |
| 06/05/2008 | US20080132448 Conserved neisserial antigens |
| 06/05/2008 | US20080131902 Personalized skin care composition and method for production thereof |
| 06/05/2008 | US20080131376 Carboranylporphyrins and uses thereof |
| 06/05/2008 | US20080131375 Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis |
| 06/05/2008 | US20080131374 Pneumococcal vaccine and tumor necrosis factor antibodies; c-reactive protein; drug screening |
| 06/05/2008 | US20080131373 Fab proteins; anticancer agents; immunoglobulins; gene expression inhibition; kits |
| 06/05/2008 | US20080131371 Oligonucleotide Non-Viral Delivery Systems |
| 06/05/2008 | US20080131370 For prophylaxis or treatment of apoptosis or inflammation-associated disease, diabetes, or chronic obstructive pulmonary disease |
| 06/05/2008 | US20080131369 Compositions And Methods For Enhancing Contrast In Imaging |
| 06/05/2008 | US20080131367 Composition For Diagnosing Amyloid-Related Diseases |
| 06/05/2008 | CA2670436A1 Novel compound having affinity for amyloid |
| 06/05/2008 | CA2664400A1 Particles for cell targeting |
| 06/04/2008 | EP1926425A2 Multiple contrast agent injection for imaging |
| 06/04/2008 | EP1126782B1 Method for improved imaging and photodynamic therapy |
| 06/04/2008 | CN201067432Y Tail fibre intramedullary nail |
| 06/04/2008 | CN101193659A Tunstern particl as x-ray contrast |
| 06/04/2008 | CN100392422C Method and devices for dissolving hyperpolarised solid material for nmr analyses |
| 06/04/2008 | CN100392082C Conserved neisserial antigens |
| 06/03/2008 | US7383076 Fluorescence-mediated molecular tomography |
| 06/03/2008 | US7381404 Treatment for dry macular degeneration |
| 06/03/2008 | US7381401 T cell anergy is reversed by active Ras and regulated by diacylglycerol kinase |
| 06/03/2008 | US7381400 Injection of a radioactive dye for sentinel lymph node identification |